JNJ vs RMD
By Alex · Tickerpine
Johnson & Johnson vs ResMed Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | RMD |
|---|---|---|
| Price | $271.22 | $222.00 |
| Market cap | $653.61B | $32.02B |
| P/E ratio | 31.5 | 21.3 |
| ROE | 25.74% | 24.27% |
| Profit margin | 21.48% | 26.95% |
| Revenue growth | 6.60% | 8.60% |
| Dividend yield | 1.98% | 1.19% |
| Beta | 0.23 | 0.77 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs RMD in plain English
- JNJ is the bigger company — about 20.4× the market cap of RMD.
- RMD is cheaper on earnings (P/E 21.3 vs 31.5).
- JNJ earns a higher return on equity (26% vs 24%).
- RMD is growing revenue faster (9% vs 7%).
- JNJ has the higher dividend yield (1.98% vs 1.19%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
RMD return calculator
See what $1,000 in ResMed Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.